Cyclacel hosts Research and Development Day
The R&D day will feature renowned KOLs in oncology and program updates from senior management.
Triple board certified in hematology, oncology and internal medicine,
Her main research interests include gastric, pancreatic and bile duct cancer, with a particular interest in translational research and early drug development. She has published over 250 peer-reviewed journal articles and serves on numerous committees, including the
This press release contains certain forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from historical results or from any future results expressed or implied by such forward-looking statements. Such forward-looking statements include, but are not limited to, statements regarding the efficacy, safety and intended use of
Tel: (908) 517-7330
Email: [email protected]